With the foundation of our seminal frequency-domain and diffuse optical spectroscopy work on neonates, we are developing novel devices and approaches to better quantify cerebral blood flow and oxygen metabolism in the clinical setting. I will present the first fully integrated FDNIRS-DCS system. I will show results of this technology in measuring infants affected by hydrocephalus in Africa, and measuring pediatric and adult patients in intensive care settings in Boston. I will conclude by describing novel optical approaches to better quantify cerebral blood flow and to assess intracranial pressure continuously and non-invasively.
